Comparison of Post-Licensure Vaccine Adverse Event Reporting System (VAERS) Reports Involving Quadrivalent Human Papillomavirus Vaccine (Gardasil®) and Meningococcal Conjugate Vaccine (Menactra®) in Females Aged 11-26 Years

被引：0
|
作者：
Davlin, Stacy [1 ]
Rupp, Richard [2 ]
Berenson, Abbey [2 ]
机构：
[1] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Galveston, TX 77555 USA
来源：
JOURNAL OF WOMENS HEALTH | 2014年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P9
引用
收藏
页码：4 / 5
页数：2
相关论文
共 33 条
  • [1] Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015
    Arana, Jorge E.
    Harrington, Theresa
    Cano, Maria
    Lewis, Paige
    Mba-Jonas, Adamma
    Li Rongxia
    Stewart, Brock
    Markowitz, Lauri E.
    Shimabukuro, Tom T.
    [J]. VACCINE, 2018, 36 (13) : 1781 - 1788
  • [2] Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016
    Myers, Tanya R.
    McNeil, Michael M.
    Ng, Carmen S.
    Li, Rongxia
    Marquez, Paige L.
    Moro, Pedro L.
    Omer, Saad B.
    Cano, Maria, V
    [J]. VACCINE, 2020, 38 (40) : 6291 - 6298
  • [3] Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, vaccine adverse event reporting system (VAERS), July 2013-June 2014
    Haber, Penina
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Stweart, Brock
    Shimabukuro, Tom T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 180 - 180
  • [4] Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014
    Haber, Penina
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Stewart, Brock
    Shimabukuro, Tom T.
    [J]. VACCINE, 2015, 33 (16) : 1987 - 1992
  • [5] Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
    David A. Geier
    Mark R. Geier
    [J]. Immunologic Research, 2017, 65 : 46 - 54
  • [6] Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015
    Myers, Tanya R.
    McNeil, Michael M.
    Ng, Carmen S.
    Li, Rongxia
    Lewis, Paige W.
    Cano, Maria V.
    [J]. VACCINE, 2017, 35 (14) : 1758 - 1763
  • [7] Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database
    Geier, David A.
    Geier, Mark R.
    [J]. IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 46 - 54
  • [8] Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013
    Miller, Elaine R.
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Bryant-Genevier, Marthe
    Shimabukuro, Tom T.
    [J]. VACCINE, 2016, 34 (25) : 2841 - 2846
  • [9] Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015
    Miller, Elaine R.
    Lewis, Paige
    Shimabukuro, Tom T.
    Su, John
    Moro, Pedro
    Woo, Emily Jane
    Jankosky, Christopher
    Cano, Maria
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 1963 - 1969
  • [10] Safety of quadrivalent human papillomavirus vaccine (Gardasil®) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013
    Moro, Pedro L.
    Zheteyeva, Yenlik
    Lewis, Paige
    Shi, Jing
    Yue, Xin
    Museru, Oidda I.
    Broder, Karen
    [J]. VACCINE, 2015, 33 (04) : 519 - 522
1234